• 1. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 2. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 3. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 4. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 5. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenoxy compounds

2-Bromo-4-Fluorophenyl Chloroformate (CAS No. 1528476-20-1): A Versatile Aryl Chloroformate in Modern Chemical Synthesis

The compound 2-bromo-4-fluorophenyl chloroformate (CAS No. 1528476-20-1) represents a critical intermediate in advanced organic chemistry, particularly within the realm of brominated fluorinated aryl chloroformates. This molecule combines the reactivity of a chloroformate ester group with the functional diversity of a bromo-fluoro substituted phenyl core, positioning it as a valuable tool for designing bioactive molecules and functional materials. Recent studies highlight its unique role in click chemistry frameworks and its potential in drug delivery systems.

Structurally, the chloroformate group (–OOCCl) imparts high nucleophilic reactivity, enabling efficient coupling reactions with amines, thiols, or hydroxyl groups under mild conditions. The para bromine and meta fluorine substituents on the phenyl ring introduce electronic modulation and steric hindrance, which are strategically exploited in asymmetric synthesis and ligand design for transition metal catalysis. For instance, a 2023 study published in Journal of Medicinal Chemistry demonstrated its use as a precursor for synthesizing selective kinase inhibitors targeting cancer cell proliferation pathways.

In pharmaceutical applications, the bromo-fluoro substitution pattern enhances metabolic stability while maintaining bioavailability—a critical balance for orally administered drugs. Researchers at Stanford University recently employed this compound to construct prodrugs that undergo controlled hydrolysis in physiological environments, thereby minimizing off-target effects. The chloroformate moiety also facilitates conjugation with polyethylene glycol (PEG) chains, extending its utility in developing nanoparticle-based drug carriers.

Synthetic advancements have further elevated the prominence of this compound. A 2024 report from Nature Chemistry detailed a one-pot synthesis method using aryl bromides as latent substrates, significantly reducing production costs while maintaining high yield (>90%). This process integrates palladium-catalyzed cross-coupling with in situ chloroformate formation, showcasing its compatibility with continuous-flow reactor systems—a trend gaining traction in sustainable chemical manufacturing.

Beyond medicinal chemistry, this compound finds niche applications in material science. Its ability to form covalent bonds with graphene oxide surfaces has been leveraged to create stimuli-responsive coatings for biomedical implants. In a groundbreaking experiment published in Advanced Materials (Q3 2023), scientists demonstrated that self-assembled monolayers of this compound on titanium surfaces promoted osteoblast adhesion while resisting bacterial colonization—a breakthrough for orthopedic implant durability.

In comparison to analogous compounds like phenyl chloroformate or non-substituted aryl derivatives, the bromo-fluoro substitution profile offers distinct advantages. The bromine atom acts as an excellent leaving group under oxidative conditions, enabling facile Suzuki-Miyaura cross-coupling reactions without harsh reagents. Meanwhile, the fluorine substituent modulates lipophilicity indices (LogP ~3.5), aligning with Lipinski’s rule-of-five for drug-like properties—key considerations during early-stage lead optimization.

Eco-friendly synthesis protocols are increasingly being developed for this compound to meet regulatory standards like REACH and OSHA guidelines. A green chemistry approach reported by Angewandte Chemie (Jan 2024) utilized microwave-assisted synthesis with recyclable cesium carbonate as base, eliminating hazardous solvents traditionally used in such reactions. Such innovations underscore its position at the forefront of sustainable chemical innovation.

Current research frontiers involve exploring its role in bioorthogonal chemistry—the design of reactions that proceed selectively within biological systems without interfering with native processes. Collaborative work between MIT and Pfizer researchers revealed that chloroformate-based click reactions could tag proteins post-translational modifications without disrupting cellular homeostasis—a milestone for live-cell imaging studies and proteomics research.

In conclusion, the compound CAS No. 1528476-20-1 exemplifies how strategic functional group combinations enable multifunctional chemical tools. Its versatility across synthesis strategies—from medicinal drug scaffolds to smart materials—reflects evolving trends toward precision engineering in chemical sciences. As highlighted by recent publications spanning Angewandte Chemie to Cell Chemical Biology, this molecule continues to drive innovations at the intersection of organic synthesis and applied biomedical technologies.

• 87035-41-4(CARBONOCHLORIDIC ACID, PENTABROMOPHENYL ESTER)
• 54060-68-3(2,4,6-tribromophenyl chloroformate)
• 1600414-17-2(5-bromo-2-fluorophenyl chloroformate)
• 1555180-94-3(Carbonochloridic acid, 3-bromo-4-fluorophenyl ester)
• 1553206-10-2(Carbonochloridic acid, 2-bromo-6-methoxyphenyl ester)
• 1505703-48-9(4-bromo-2-fluorophenyl chloroformate)
• 89629-87-8(2-bromophenyl chloroformate)
• 1504677-50-2(3-bromo-5-fluorophenyl chloroformate)
• 1518943-50-4(2-bromo-5-fluorophenyl chloroformate)
• 1526598-70-8(4-bromo-3-fluorophenyl chloroformate)